Segment Disclosures - Summary Information for the Reportable Segments (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)	Dec. 31, 2020 property	Jan. 31, 2020 property
Segment Disclosure
Property count | property						15
Tax benefit recognized in conjunction with internal restructuring activities		$ 52,000
Tax benefit recognized from CARES Act		3,600
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	$ 476,238	408,559	$ 931,514	$ 789,613
Government grant income	87	11,871	1,397	11,871
Less: Interest income	(16,108)	(4,230)	(25,121)	(7,918)
Healthpeak’s share of unconsolidated joint venture total revenues	21,277	24,154	44,570	66,690
Healthpeak’s share of unconsolidated joint venture government grant income	583	804	1,009	804
Noncontrolling interests’ share of consolidated joint venture total revenues	(8,900)	(8,404)	(17,891)	(17,096)
Operating expenses	(190,132)	(177,808)	(371,893)	(415,185)
Healthpeak’s share of unconsolidated joint venture operating expenses	(15,404)	(18,783)	(33,463)	(50,373)
Noncontrolling interests’ share of consolidated joint venture operating expenses	2,573	2,525	5,097	5,142
Adjustments to NOI	(13,170)	(3,127)	(26,771)	83,112
Adjusted NOI	257,044	235,561	508,448	466,660
Plus: Adjustments to NOI	13,170	3,127	26,771	(83,112)
Interest income	16,108	4,230	25,121	7,918
Interest expense	(38,681)	(54,823)	(85,524)	(110,514)
Depreciation and amortization	(171,459)	(139,691)	(328,997)	(264,803)
General and administrative	(24,088)	(23,720)	(48,990)	(46,069)
Transaction costs	(619)	(373)	(1,417)	(14,936)
Impairments and loan loss reserves	(931)	(6,837)	(4,173)	(17,944)
Gain (loss) on sales of real estate, net	175,238	81,284	175,238	83,353
Gain (loss) on debt extinguishments	(60,865)	(25,824)	(225,157)	(24,991)
Other income (expense), net	1,734	17,415	3,934	228,068
Less: Government grant income	(87)	(11,871)	(1,397)	(11,871)
Less: Healthpeak’s share of unconsolidated joint venture NOI	(6,456)	(6,175)	(12,116)	(17,121)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI	6,327	5,879	12,794	11,954
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	166,435	78,182	44,535	206,592
Income tax benefit (expense)	763	(106)	755	29,762
Equity income (loss) from unconsolidated joint ventures	867	(17,735)	2,190	(28,881)
Income (loss) from continuing operations	168,065	60,341	47,480	207,473
Income (loss) from discontinued operations	113,960	(5,292)	383,968	130,116
Net income (loss)	282,025	55,049	431,448	337,589
Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	476,238	408,559	931,514	789,613
Corporate Non-segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	0	0	0	0
Government grant income	0	0	0	0
Less: Interest income	0	0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues	0	0	0	0
Healthpeak’s share of unconsolidated joint venture government grant income	0	0	0	0
Noncontrolling interests’ share of consolidated joint venture total revenues	0	0	0	0
Operating expenses	0	0	0	0
Healthpeak’s share of unconsolidated joint venture operating expenses	0	0	0	0
Noncontrolling interests’ share of consolidated joint venture operating expenses	0	0	0	0
Adjustments to NOI	0	0	0	0
Adjusted NOI	0	0	0	0
Plus: Adjustments to NOI	0	0	0	0
Interest income	0	0	0	0
Interest expense	(35,923)	(52,694)	(80,651)	(106,916)
Depreciation and amortization	0	0	0	0
General and administrative	(24,088)	(23,720)	(48,990)	(46,069)
Transaction costs	0	0	0	0
Impairments and loan loss reserves	0	0	0	0
Gain (loss) on sales of real estate, net	0	0	0	0
Gain (loss) on debt extinguishments	(60,865)	(25,824)	(225,157)	(24,991)
Other income (expense), net	1,716	3,273	3,532	1,887
Less: Government grant income	0	0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI	0	0	0	0
Plus: Noncontrolling interests’ share of consolidated joint venture NOI	0	0	0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	(119,160)	(98,965)	(351,266)	(176,089)
Income tax benefit (expense)	763	(106)	755	29,762
Equity income (loss) from unconsolidated joint ventures	0	0	0	0
Income (loss) from continuing operations	(118,397)	(99,071)	(350,511)	(146,327)
Income (loss) from discontinued operations	113,960	(5,292)	383,968	130,116
Net income (loss)	(4,437)	(104,363)	33,457	(16,211)
Life Science
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Depreciation and amortization	(11,000)		(15,000)
Income (loss) from continuing operations	(11,000)		(15,000)
Life Science | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	177,527	138,496	347,461	267,379
Government grant income	0	0	0	0
Less: Interest income	0	0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues	1,412	0	2,749	0
Healthpeak’s share of unconsolidated joint venture government grant income	0	0	0	0
Noncontrolling interests’ share of consolidated joint venture total revenues	(75)	(57)	(140)	(109)
Operating expenses	(40,724)	(34,205)	(80,185)	(64,406)
Healthpeak’s share of unconsolidated joint venture operating expenses	(428)	0	(853)	0
Noncontrolling interests’ share of consolidated joint venture operating expenses	21	18	41	35
Adjustments to NOI	(12,366)	(2,779)	(24,176)	(7,059)
Adjusted NOI	125,367	101,473	244,897	195,840
Plus: Adjustments to NOI	12,366	2,779	24,176	7,059
Interest income	0	0	0	0
Interest expense	(48)	(60)	(150)	(122)
Depreciation and amortization	(76,955)	(52,356)	(145,388)	(102,567)
General and administrative	0	0	0	0
Transaction costs	21	(1)	(11)	(1)
Impairments and loan loss reserves	0	0	0	0
Gain (loss) on sales of real estate, net	0	0	0	0
Gain (loss) on debt extinguishments	0	0	0	0
Other income (expense), net	28	0	33	0
Less: Government grant income	0	0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI	(984)	0	(1,896)	0
Plus: Noncontrolling interests’ share of consolidated joint venture NOI	54	39	99	74
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	59,849	51,874	121,760	100,283
Income tax benefit (expense)	0	0	0	0
Equity income (loss) from unconsolidated joint ventures	111	0	18	0
Income (loss) from continuing operations	59,960	51,874	121,778	100,283
Income (loss) from discontinued operations	0	0	0	0
Net income (loss)	59,960	51,874	121,778	100,283
Medical Office | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	165,295	151,844	325,496	308,485
Government grant income	0	0	0	0
Less: Interest income	0	0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues	710	691	1,425	1,386
Healthpeak’s share of unconsolidated joint venture government grant income	0	0	0	0
Noncontrolling interests’ share of consolidated joint venture total revenues	(8,825)	(8,347)	(17,751)	(16,987)
Operating expenses	(54,648)	(49,355)	(105,769)	(100,049)
Healthpeak’s share of unconsolidated joint venture operating expenses	(317)	(276)	(611)	(551)
Noncontrolling interests’ share of consolidated joint venture operating expenses	2,552	2,507	5,056	5,107
Adjustments to NOI	(2,003)	(465)	(3,926)	(1,459)
Adjusted NOI	102,764	96,599	203,920	195,932
Plus: Adjustments to NOI	2,003	465	3,926	1,459
Interest income	0	0	0	0
Interest expense	(786)	(100)	(881)	(203)
Depreciation and amortization	(63,371)	(55,904)	(121,326)	(110,571)
General and administrative	0	0	0	0
Transaction costs	35	0	(295)	0
Impairments and loan loss reserves	0	(2,119)	0	(4,825)
Gain (loss) on sales of real estate, net	175,238	81,284	175,238	83,393
Gain (loss) on debt extinguishments	0	0	0	0
Other income (expense), net	(175)	0	(2,454)	0
Less: Government grant income	0	0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI	(393)	(415)	(814)	(835)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI	6,273	5,840	12,695	11,880
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	221,588	125,650	270,009	176,230
Income tax benefit (expense)	0	0	0	0
Equity income (loss) from unconsolidated joint ventures	137	210	328	407
Income (loss) from continuing operations	221,725	125,860	270,337	176,637
Income (loss) from discontinued operations	0	0	0	0
Net income (loss)	221,725	125,860	270,337	176,637
CCRC | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	117,308	113,926	233,436	205,706
Government grant income	87	11,871	1,397	11,871
Less: Interest income	0	0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues	2,415	4,781	6,903	26,428
Healthpeak’s share of unconsolidated joint venture government grant income	0	534	199	534
Noncontrolling interests’ share of consolidated joint venture total revenues	0	0	0	0
Operating expenses	(94,760)	(94,248)	(185,939)	(250,730)
Healthpeak’s share of unconsolidated joint venture operating expenses	(2,208)	(4,826)	(6,953)	(22,863)
Noncontrolling interests’ share of consolidated joint venture operating expenses	0	0	0	0
Adjustments to NOI	1,226	18	1,246	91,579
Adjusted NOI	24,068	32,056	50,289	62,525
Plus: Adjustments to NOI	(1,226)	(18)	(1,246)	(91,579)
Interest income	0	0	0	0
Interest expense	(1,924)	(1,969)	(3,842)	(3,273)
Depreciation and amortization	(31,133)	(31,426)	(62,283)	(51,655)
General and administrative	0	0	0	0
Transaction costs	(657)	(368)	(1,090)	(14,842)
Impairments and loan loss reserves	0	0	0	0
Gain (loss) on sales of real estate, net	0	0	0	0
Gain (loss) on debt extinguishments	0	0	0	0
Other income (expense), net	165	14,142	2,341	184,474
Less: Government grant income	(87)	(11,871)	(1,397)	(11,871)
Less: Healthpeak’s share of unconsolidated joint venture NOI	(207)	(489)	(149)	(4,099)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI	0	0	0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	(11,001)	57	(17,377)	69,680
Income tax benefit (expense)	0	0	0	0
Equity income (loss) from unconsolidated joint ventures	639	401	639	(1,479)
Income (loss) from continuing operations	(10,362)	458	(16,738)	68,201
Income (loss) from discontinued operations	0	0	0	0
Net income (loss)	(10,362)	458	(16,738)	68,201
Other non-reportable | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	16,108	4,293	25,121	8,043
Government grant income	0	0	0	0
Less: Interest income	(16,108)	(4,230)	(25,121)	(7,918)
Healthpeak’s share of unconsolidated joint venture total revenues	16,740	18,682	33,493	38,876
Healthpeak’s share of unconsolidated joint venture government grant income	583	270	810	270
Noncontrolling interests’ share of consolidated joint venture total revenues	0	0	0	0
Operating expenses	0	0	0	0
Healthpeak’s share of unconsolidated joint venture operating expenses	(12,451)	(13,681)	(25,046)	(26,959)
Noncontrolling interests’ share of consolidated joint venture operating expenses	0	0	0	0
Adjustments to NOI	(27)	99	85	51
Adjusted NOI	4,845	5,433	9,342	12,363
Plus: Adjustments to NOI	27	(99)	(85)	(51)
Interest income	16,108	4,230	25,121	7,918
Interest expense	0	0	0	0
Depreciation and amortization	0	(5)	0	(10)
General and administrative	0	0	0	0
Transaction costs	(18)	(4)	(21)	(93)
Impairments and loan loss reserves	(931)	(4,718)	(4,173)	(13,119)
Gain (loss) on sales of real estate, net	0	0	0	(40)
Gain (loss) on debt extinguishments	0	0	0	0
Other income (expense), net	0	0	482	41,707
Less: Government grant income	0	0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI	(4,872)	(5,271)	(9,257)	(12,187)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI	0	0	0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	15,159	(434)	21,409	36,488
Income tax benefit (expense)	0	0	0	0
Equity income (loss) from unconsolidated joint ventures	(20)	(18,346)	1,205	(27,809)
Income (loss) from continuing operations	15,139	(18,780)	22,614	8,679
Income (loss) from discontinued operations	0	0	0	0
Net income (loss)	$ 15,139	$ (18,780)	$ 22,614	$ 8,679
Lessor Asset Under Operating Lease | Other non-reportable
Segment Disclosure
Property count | property					1